RecruitingNCT06920459

Zimmer Biomet Shoulder Arthroplasty PMCF Study

Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study


Sponsor

Zimmer Biomet

Enrollment

50 participants

Start Date

Apr 29, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This is a multicenter, prospective, non-controlled post market surveillance study. The objectives of this study are to confirm the safety, performance, and clinical benefits of the Zimmer Biomet Shoulder Arthroplasty systems in primary anatomic shoulder arthroplasty and its instrumentation. Safety of the systems will be assessed by monitoring the frequency and incidence of adverse events. The performance and clinical benefits will be evaluated by assessment of the overall pain and functional performance, qualify of life, and radiographic parameters of all enrolled study subjects.


Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Alliance™ Glenoid for people with arthritis shoulder, degenerative joint disease, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 20 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAlliance™ Glenoid

Total Shoulder Arthroplasty using the Alliance™ Glenoid implant


Locations(2)

ARCUS Kliniken Pforzheim

Pforzheim, Germany

Meander Medisch Centrum

Amersfoort, TZ, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06920459


Related Trials